Amlodipine Besylate Tablet
Product Images NDC 67296-1876

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 67296-1876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)
Chemical structure of Amlodipine Besylate showing its molecular arrangement including benzene ring, chlorine atom, and other attached functional groups.*
FDA Label Image

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)
A Kaplan-Meier curve graph showing event rates over time in months, comparing Amlodipine and placebo groups. The event rate is plotted on the y-axis, and time in months on the x-axis. The graph includes a p-value of 0.003 and a hazard ratio of 0.691 with a 95% confidence interval of 0.54 to 0.88, indicating statistical analysis results.*
FDA Label Image

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)
A forest plot illustrating hazard ratios with 95% confidence intervals for various patient subgroups comparing amlodipine to placebo. Subgroups include overall patients, age (<65 and ≥65), gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis represents hazard ratios from 0.0 to 2.0, with a vertical line at 1.0 indicating no effect.*
FDA Label Image

Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 04)

FDA Label Image

Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 05)

FDA Label Image

2.5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 06)

2.5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 06)
Label for Amlodipine Besylate Tablets, USP 2.5 mg strength. The label shows a package of 90 tablets for oral use, manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc. Storage instructions and pharmacist dispenser notes are also included, along with a barcode and NDC 29300-396-19.*
FDA Label Image

5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 07)

5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 07)
A medication label for Amlodipine Besylate Tablets, USP 5 mg. The label indicates a package containing 90 tablets. It includes storage instructions, a barcode, and manufacturer information: Unichem Laboratories Ltd. in India, and Unichem Pharmaceuticals (USA) Inc. in New Jersey. The label mentions pharmacist dispensing requirements and usage precautions.*
FDA Label Image

10mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 08)

10mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 08)
Amlodipine Besylate 10 mg tablets label showing the drug name, dosage strength, and form. The label includes NDC 29300-398-19 and states 90 tablets per container. It specifies pharmacist dispensing instructions and storage conditions. Manufactured by Unichem Laboratories Ltd. in India, for Unichem Pharmaceuticals (USA), Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.